for Grindex

Update: 14.03.2021

Last week: 9 week 2022 (28.02.2022 - 6.03.2022)

Last full month: Feb 2021

STRATEGIC VIEW


9я неделя (с 28.02 по 06.03) стала стрессовой для многих категорий

Очевидные причины – закупка впрок на фоне валютных скачков и возможных логистических проблем

В качестве бенчмарка – рост продаж инсулина (Новорапид - +213% WoW, Лантус - +316% WoW) По брендам Grindex следующая ситуация:

МИЛДРОНАТ

Прирост продаж в упаковках (Week-over-Week) на 59,8%

Ускорилась уходимость новых SKU по новым ценам - #20 250mg и #60 500 mg - до 1,5-2 тыс за неделю. Скачкообразный рост спроса и вымывания по старым ценам ускоряет «расправление плеч» новых sku

ВИПРОСАЛ

Рост продаж в упаковках (Week-over-Week) на 56,2%

Немного быстрее, чем категория в целом – это хороший знак силы обновленного бренда Пока не исследовали вопрос дефектуры, но в целом на этих значениях роста – это скорее локальное вымывание в отдельных аптеках

КАПСИКАМ

Рост продаж в упаковках (Week-over-Week) на 25,4% Темпы роста в 2 раза ниже категории – нужно разбираться в причинах. Одна из скрытых и неочевидных на первый взгляд – меньший процент регулярных «хронических» потребителей, которые пополняют запасы загодя

СУЛЬФАРГИН

Рост продаж в упаковках (Week-over-Week) на 21,8%

Значимо ниже прироста категории – вероятнее всего потребители делали фокус на закупках дорогих западных препаратов

Очевидно, что дефектура, как в случае и с Капсикамом – минимальна

АПИЛАК

Рост продаж в упаковках (Week-over-Week) на 24,7%

Неделя без больших аномалий. По сути, за 7 дней продали столько, сколько должны были продавать за 9

У всех брендов прирост выше по большим упаковкам, прирост средней цены практически по всем SKU - на 10-20% (скорее всего потому, что просто покупали везде, в том числе в дорогих аптеках)


BRAND PORTFOLIO PERFORMANCE

One-pager

Time period Volume Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat.Vol, Change
APILAC
WoW 3 592 24.7% 58.4% -0.2 1 672 573 29.5% 84.3% 0 25.1%
MoM 11 577 16.9% 55.7% 4.2 5 204 099 19.8% 82.7% 2.8 8.1%
YTD 24 266 5.1% 54.5% -4.2 10 854 223 32.9% 81.9% 0.6 13.2%
MAT 118 787 -21.7% 54.8% -6.7 48 298 627 3.6% 80.4% -0.7 -12.1%
CAPSICAM
WoW 27 570 25.4% 3.0% -0.7 11 779 407 30.1% 2.7% -1 54.9%
MoM 184 740 -6.2% 3.7% -0.2 75 707 986 -6.3% 3.8% -0.3 -1.2%
YTD 208 565 -9.4% 3.6% -0.3 85 909 077 -11.5% 3.7% -0.9 -2.0%
MAT 1 043 422 -20.6% 3.3% -0.4 427 829 990 -12.8% 3.6% -0.5 -11.1%
MILDRONATE
WoW 202 142 59.8% 23.2% 0.7 117 534 769 87.1% 22.7% 1 54.9%
MoM 507 422 17.9% 21.8% 1 242 156 427 38.3% 20.6% 2.7 12.5%
YTD 1 090 192 25.6% 16.6% 1.8 509 976 818 37.6% 16.2% 2 12.0%
MAT 5 018 000 11.4% 16.8% 2.6 2 072 772 436 16.3% 15.0% 2.1 -5.9%
SULFARGIN
WoW 4 086 21.8% 0.7% -0.2 2 044 022 25.6% 0.9% -0.4 54.8%
MoM 14 059 2.0% 1.0% 0 6 756 585 0.2% 1.3% 0 2.0%
YTD 30 407 5.2% 0.9% 0.1 14 800 201 9.7% 1.3% 0.2 -6.3%
MAT 165 661 -20.2% 0.8% -0.1 81 066 416 -8.7% 1.2% 0 -10.8%
VIPROSAL
WoW 43 906 56.2% 4.4% 0.1 18 719 558 67.6% 4.1% -0.3 52.7%
MoM 122 479 0.5% 4.5% 0.1 48 514 619 1.0% 4.5% 0 -1.7%
YTD 274 751 37.0% 4.4% 1.2 109 688 881 41.4% 4.4% 1 -0.1%
MAT 1 317 726 -4.6% 3.9% 0.3 503 366 451 2.8% 3.9% 0.1 -11.9%

WoW

Brand Volume Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat.Vol, Change
APILAC 3 592 24.7% 58.4% -0.2 1 672 573 29.5% 84.3% 0 25.1%
KAPSIKAM 27 570 25.4% 3.0% -0.7 11 779 407 30.1% 2.7% -1 54.9%
MILDRONATE 202 142 59.8% 23.2% 0.7 117 534 769 87.1% 22.7% 1 54.9%
SULFARGIN 4 086 21.8% 0.7% -0.2 2 044 022 25.6% 0.9% -0.4 54.8%
VIPROSAL 43 906 56.2% 4.4% 0.1 18 719 558 67.6% 4.1% -0.3 52.7%

MoM

Brand Volume Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat.Vol, Change
APILAC 11 577 16.9% 55.7% 4.2 5 204 099 19.8% 82.7% 2.8 8.1%
KAPSIKAM 184 740 -6.2% 3.7% -0.2 75 707 986 -6.3% 3.8% -0.3 -1.2%
MILDRONATE 507 422 17.9% 21.8% 1 242 156 427 38.3% 20.6% 2.7 12.5%
SULFARGIN 14 059 2.0% 1.0% 0 6 756 585 0.2% 1.3% 0 2.0%
VIPROSAL 122 479 0.5% 4.5% 0.1 48 514 619 1.0% 4.5% 0 -1.7%

YTD

Brand Volume Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat.Vol, Change
APILAC 24 266 5.1% 54.5% -4.2 10 854 223 32.9% 81.9% 0.6 13.2%
KAPSIKAM 208 565 -9.4% 3.6% -0.3 85 909 077 -11.5% 3.7% -0.9 -2.0%
MILDRONATE 1 090 192 25.6% 16.6% 1.8 509 976 818 37.6% 16.2% 2 12.0%
SULFARGIN 30 407 5.2% 0.9% 0.1 14 800 201 9.7% 1.3% 0.2 -6.3%
VIPROSAL 274 751 37.0% 4.4% 1.2 109 688 881 41.4% 4.4% 1 -0.1%

MAT

Brand Volume Change, % MS Volume Change, p.p. Value, rur Change, % MS Value Change, p.p. Cat.Vol, Change
APILAC 118 787 -21.7% 54.8% -6.7 48 298 627 3.6% 80.4% -0.7 -12.1%
KAPSIKAM 1 043 422 -20.6% 3.3% -0.4 427 829 990 -12.8% 3.6% -0.5 -11.1%
MILDRONATE 5 018 000 11.4% 16.8% 2.6 2 072 772 436 16.3% 15.0% 2.1 -5.9%
SULFARGIN 165 661 -20.2% 0.8% -0.1 81 066 416 -8.7% 1.2% 0 -10.8%
VIPROSAL 1 317 726 -4.6% 3.9% 0.3 503 366 451 2.8% 3.9% 0.1 -11.9%

VIPROSAL


VALUE & VOLUME DYNAMICS

VOLUME


VALUE

MS VOLUME

MS VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


MEDIA COSTS vs SALES (monthly)

Total Sales

## [1] "VIPROSAL"

SKU #1

## [1] "VIPROSAL B UNGUENT FOR EXT USE 30 G #1"

SKU #2

## [1] "VIPROSAL B UNGUENT FOR EXT USE 50 G #1"

SKU #3

## [1] "VIPROSAL B UNGUENT FOR EXT USE 75 G #1"

TRPS vs SALES (weekly)

Total Sales

## [1] "VIPROSAL"

SKU #1

## [1] "VIPROSAL B UNGUENT FOR EXT USE 30 G #1"

SKU #2

## [1] "VIPROSAL B UNGUENT FOR EXT USE 50 G #1"

SKU #3

## [1] "VIPROSAL B UNGUENT FOR EXT USE 75 G #1"

MS OF COMPETITORS: VIPROSAL COMPETITORS

MS VOLUME (weekly)


MS VALUE (weekly)

MS VOLUME (monthly)

MS VALUE (monthly)


KAPSIKAM


BRAND VALUE & VOLUME DYNAMICS

MS VOLUME


MS VALUE

VOLUME

VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


MEDIA COSTS vs SALES (monthly)

Total Sales

## [1] "KAPSIKAM"

SKU #1

## [1] "KAPSIKAM UNGUENT FOR EXT USE 30 G #1"

SKU #2

## [1] "KAPSIKAM UNGUENT FOR EXT USE 50 G #1"

TRPS vs SALES (weekly)

Total Sales

## [1] "KAPSIKAM"

SKU #1

## [1] "KAPSIKAM UNGUENT FOR EXT USE 30 G #1"

SKU #2

## [1] "KAPSIKAM UNGUENT FOR EXT USE 50 G #1"

MS OF COMPETITORS: KAPSIKAM COMPETITORS

MS VOLUME (weekly)


MS VALUE (weekly)

MS VOLUME (monthly)

MS VALUE (monthly)


MILDRONATE


VALUE & VOLUME DYNAMICS

VOLUME


VALUE

MS VOLUME

MS VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


MEDIA COSTS vs SALES (monthly)

Total Sales

## [1] "MILDRONATE CAPS 500 MG #30"

SKU #1

## [1] "MILDRONATE CAPS 250 MG #20"

SKU #2

## [1] "MILDRONATE CAPS 250 MG #40"

SKU #3

## [1] "MILDRONATE CAPS 500 MG #30"

SKU #4

## [1] "MILDRONATE CAPS 500 MG #60"

TRPS vs SALES (weekly)

Total Sales

## [1] "MILDRONATE CAPS 500 MG #30"

SKU #1

## [1] "MILDRONATE CAPS 250 MG #20"

SKU #2

## [1] "MILDRONATE CAPS 250 MG #40"

SKU #3

## [1] "MILDRONATE CAPS 500 MG #30"

SKU #4

## [1] "MILDRONATE CAPS 500 MG #60"

MS OF COMPETITORS: CARDIOLOGICAL PREPARATIONS BASED ON MELDONIUM

MS VOLUME (weekly)


MS VALUE (weekly)

MS VOLUME (monthly)

MS VALUE (monthly)


SULFARGIN


BRAND VALUE & VOLUME DYNAMICS

MS VOLUME


MS VALUE

VOLUME

VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


MEDIA COSTS vs SALES (monthly)

Total Sales

## [1] "SULFARGIN"

SKU #1

## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 15 G #1"

SKU #2

## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 50 G #1"

TRPS vs SALES (weekly)

Total Sales

## [1] "SULFARGIN"

SKU #1

## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 15 G #1"

SKU #2

## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 50 G #1"

MS OF COMPETITORS: TREATMENT OF WOUNDS AND BURNS

MS VOLUME (weekly)


MS VALUE (weekly)

MS VOLUME (monthly)

MS VALUE (monthly)


APILAC


BRAND VALUE & VOLUME DYNAMICS

MS VOLUME


MS VALUE

VOLUME

VALUE


SKU VOLUME DYNAMICS

VOLUME MAT


VOLUME YTD

VOLUME WoW

VOLUME MoM


MEDIA COSTS vs SALES (monthly)

Total Sales

## [1] "APILAC"

SKU #1

## [1] "APILAC TABS 10 MG #25"

SKU #2

## [1] "APILAC TABS 10 MG #50"

TRPS vs SALES (weekly)

Total Sales

## [1] "APILAC"

SKU #1

## [1] "APILAC TABS 10 MG #25"

SKU #2

## [1] "APILAC TABS 10 MG #50"

MS OF COMPETITORS: APILAC

MS VOLUME (weekly)


MS VALUE (weekly)

MS VOLUME (monthly)

MS VALUE (monthly)

REFERENCE

Abbreviations

WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1

MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1

YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date

MAT - Moving Annual Total - a period, being any 12 month period ending on the last week

MS - Market Share

Data Sources:

DSM: Sales

Palomars: TRPs

MI: Fact Digital Costs

MI Estimated Costs: TV costs